Investor Presentaiton
Q2 2019 Results
$ in Canadian millions, unless otherwise noted
HORIZONTALLY
DIVERSIFIED
Q2 2019
Q1 2019
Change (%)
Q2 2018
Change (%)
VERTICALLY
INTEGRATED
Financial
Net Revenue
$54.2
$29.7
83%
$11.7
363%
Gross Margin on Net Cannabis Revenue(¹)
54%
70%
(23%)
63%
(15%)
Biological Inventory
$89.1
$80.8
10%
$17.3
418%
Cash Cost to Produce (per gram of dried cannabis sold) (2)
$1.92
$1.45
33%
$1.41
22%
Operational
Average Net Selling Price of Dried Cannabis
Average Net Selling Price of Cannabis Extracts
$6.23
$8.39
(26%)
$7.86
(21%)
$10.00
$12.12
(18%)
$13.35
(25%)
Kilograms Produced
7,822
4,996
57%
1,204
550%
Kilograms Sold
6,999
2,676
162%
1,162
502%
1. Represents the gross margin on net cannabis revenue before fair value adjustments. Excludes revenues from patient counselling services, design, engineering, and construction services, and analytical testing services. Gross margin on net cannabis revenue is a non-
IFRS financial measure. See "Gross Margin" section of Q2 2019 MD&A for reconciliation to IFRS figure.
2. Represents the cash cost of sales per gram of dried cannabis produced and sold by consolidated Aurora, excluding costs to sell such as packaging costs. Cash cost of sales per gram produced is a non-IFRS financial measure. See "Cash Cost of Sales of Dried
Cannabis and Cash Cost to Produce Dried Cannabis Sold - Aurora Produced Cannabis" section of Q2 2019 MD&A for reconciliation to IFRS figure.
AURORA
19View entire presentation